Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RLAY
#1787
Relay Therapeutics, Inc. Common Stock
14.7
5
USD
-3.34%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.34%
Monthly Change
+41.42%
6 month change
+144.21%
Year Change
+490.00%
Previous Close
15.2
6
Open
14.7
5
Bid
Ask
Low
14.7
5
High
14.7
5
Volume
142
Markets
US Stock Market
Healthcare
RLAY
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
90.4 M
108.28 M
121.38 M
131.18 M
169.52 M
178.73 M
—
Valuation ratios
Enterprise value
3.85 B
3.05 B
1.67 B
1.41 B
574.14 M
1.43 B
3.08 B
Price to earnings ratio
—
—
-5.81
-4.25
-1.75
-5.25
-11.28
Price to sales ratio
—
—
1 222.3
56.88
58.82
94.54
328.24
Price to cash flow ratio
—
—
-7.36
-4.84
-2.36
-6.17
-13.04
Price to book ratio
—
—
1.78
1.93
0.76
2.56
3.17
Enterprise value to EBITDA ratio
-73.05
-9.19
-5.69
-3.73
-1.51
-4.7
-9.52
Profitability ratios
Return on assets %
-0.07
-0.36
-0.26
-0.41
-0.39
-0.44
-0.39
Return on equity %
-0.07
-0.41
-0.31
-0.45
-0.43
-0.49
-0.43
Return on invested capital %
-65.63
-278.88
-147.72
-187.57
-214.71
-197.28
—
Gross margin %
100
100
100
100
100
100
300
Operating margin %
-67.51
-1 204.02
-21.67 K
-1 460.11
-3 722.07
-1 971.59
-8.05 M
EBITDA margin %
-63.72
-1 094.29
-21.29 K
-1 481.62
-3 790.54
-1 980.66
—
Net margin %
-63.41
-1 201.29
-21.04 K
-1 338.66
-3 374.72
-1 800.58
7.4 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
56.49
40.14
16
25.44
15.95
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.1
0.03
0
0.03
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.04
-2.45
-1.74
-1.37
-1.38
EBIT per share
—
—
-2.67
-3.04
-2.61
-1.76
-1.77
EBITDA per share
—
—
-2.62
-3.09
-2.66
-1.77
-1.78
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.35
1.17
0.87
0.49
2.24
Net current asset value per share
—
—
9.08
6.28
5.66
3.37
15.33
Tangible book value per share
—
—
8.45
6.12
5.43
3.3
14.96
Working capital per share
—
—
8.52
6.04
5.31
3.22
14.59
Book value per share
—
—
8.47
6.13
5.44
3.3
14.98
News
Oppenheimer reiterates Relay Therapeutics stock rating on trial data
Relay reports phase 1/2 data for breast cancer drug zovegalisib
Guggenheim raises Relay Therapeutics price target on VM opportunity
Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?
Relay Therapeutics: Breakthrough Designation Sets Stage For Zovegalisib Data Catalyst
Citizens reiterates Relay Therapeutics stock rating ahead of data
Relay Therapeutics stock hits 52-week high at 9.64 USD
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Relay Therapeutics earnings in spotlight after FDA breakthrough
Relay earnings in focus as FDA breakthrough fuels optimism
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status